Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises in connection with the sale of Fiskarhedenvillan
Mandate

Vinge advises in connection with the sale of Fiskarhedenvillan

March 17, 2020 M&A

Vinge has advised Litorina and other shareholders in connection with the sale of Fiskarhedenvillan to the company’s CEO and a group of industrial partners.

Fiskarhedenvillan sells residential properties primarily to private individuals in Sweden, Denmark and Finland and has a turnover of approximately SEK 700 million on an annual basis.

Vinge’s team primarily consisted of Johan Winnerblad, Joacim Rydergård, Anna Thoms, Olivia Belding, Rikard Lindahl, William Kåge, Louise Brorsson Salomon and Viktoria Owetz Leyva.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025